Bio-Techne (TECH)

Bio-Techne (TECH) Financial Statements


Bio-Techne Financial Overview

Bio-Techne's market cap is currently ―. The company's EPS TTM is $1.258; its P/E ratio is 61.28; and it has a dividend yield of 0.41%. Bio-Techne is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 272.60M$ 276.94M$ 301.32M$ 294.15M$ 271.58M
Gross Profit$ 176.59M$ 185.19M$ 204.70M$ 202.16M$ 183.36M
EBIT$ 37.72M$ 54.45M$ 96.32M$ 78.83M$ 67.89M
EBITDA$ 65.52M$ 82.99M$ 123.25M$ 105.80M$ 94.59M
Net Income Common Stockholders$ 27.46M$ 50.99M$ 75.37M$ 70.22M$ 50.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 135.65M$ 148.66M$ 204.31M$ 157.20M$ 196.76M
Total Assets$ 2.73B$ 2.76B$ 2.64B$ 2.60B$ 2.36B
Total Debt$ 555.70M$ 549.53M$ 454.96M$ 473.99M$ 289.16M
Net Debt$ 420.05M$ 400.87M$ 250.66M$ 316.79M$ 92.40M
Total Liabilities$ 767.19M$ 757.61M$ 672.18M$ 710.01M$ 536.29M
Stockholders Equity$ 1.96B$ 2.00B$ 1.97B$ 1.89B$ 1.83B
Cash Flow-
Free Cash Flow$ 68.25M$ 45.79M$ 72.56M$ 38.79M$ 58.27M
Operating Cash Flow$ 83.12M$ 59.38M$ 83.39M$ 50.53M$ 64.38M
Investing Cash Flow$ -23.67M$ -154.11M$ -4.76M$ -241.10M$ -109.00K
Financing Cash Flow$ -81.40M$ 71.51M$ -24.23M$ 150.84M$ -72.19M
Currency in USD

Bio-Techne Earnings and Revenue History

Bio-Techne Debt to Assets

Bio-Techne Cash Flow

Bio-Techne Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis